Clinical Evaluation of the Efficacy of a Nasal Spray in the Treatment of Nasal Dryness
ConditionNasal Dryness
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorYSLab
About this trial
The purpose of this study is to see whether the nasal spray can help improve hydration of the nasal mucosa, reduce discomfort linked to nasal dryness, and confirm its safety in patients suffering from nasal dryness.
Eligibility criteria
Qualifiers
Gender: female and/or male.
The physician's score for at least two symptoms, in addition to a dry nose, must average at least 2 at the enrolment visit (Day 0), for a minimum total score of 6.
Subjects agree to refrain from taking any medication and/or taking any action to relieve nasal symptoms throughout the study, from Day -4 to Day 7, apart from acetaminophen.
Autonomous adult, or minor with the consent of their legal representative.
Disqualifiers
Subjects taking anticoagulants, antihistamines, nonsteroidal anti-inflammatory drugs (NSAIDs), or topical or systemic decongestants within two weeks prior to Visit 1 and during the study.
Subjects using other nasal sprays, nasal pumps, nasal irrigation/rinsing devices, or oils, creams, or gels in the nose within two weeks prior to Visit 1 and during the study.
Subjects with a history of sensitivity to products related to the product being evaluated.
Subjects with any clinically significant comorbid condition that, in the opinion of the principal investigator, could affect the subject's safety and/or participation in the study.
Trial design
Treatments tested in this trial
- Spray pompe nasal
Treatment groups
60 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
YSLab
Lead sponsor
Eurofins
Collaborator
Source ClinicalTrials.gov